Catheter Precision Secures Tender From Leading Hospital in Hungary

Catheter Precision Secures Tender From Leading Hospital in Hungary GlobeNewswire December 03, 2025 FORT MILL, S.C., Dec. 03, 2025 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (NYSE American: VTAK), a leading U.S.-based medical device company focusing on advanced solutions in the cardiac electrophysiology market, is proud to announce that its VIVO(TM) system has successfully secured a […]

MoneyHero Group Expands Hong Kong Digital Asset Wealth Product Offerings in Collaboration with HashKey Group

MoneyHero Group Expands Hong Kong Digital Asset Wealth Product Offerings in Collaboration with HashKey Group GlobeNewswire December 03, 2025 HONG KONG, Dec. 03, 2025 (GLOBE NEWSWIRE) — MoneyHero Limited (NASDAQ: MNY) (“MoneyHero” or the “Company”), a leading tech- and AI-powered personal finance aggregation and comparison platform and a digital insurance brokerage provider in Greater Southeast

VitalEdge Launches Insights Agent to Elevate Data-Driven Decision Making for Heavy Equipment Dealers

VitalEdge Launches Insights Agent to Elevate Data-Driven Decision Making for Heavy Equipment Dealers Insights Agent Combines VitalEdge Data and Microsoft Copilot AI to Transform Dealer Operations GlobeNewswire December 03, 2025 CARY, N.C., Dec. 03, 2025 (GLOBE NEWSWIRE) — VitalEdge Technologies, the leading global provider of dealer management solutions for heavy equipment dealers, today announced the

Nexalin Technology Completes FDA Q-Submission Meeting for Gen-2 SYNC(TM) Neurostimulation Console in Alzheimer’s Disease Program

Nexalin Technology Completes FDA Q-Submission Meeting for Gen-2 SYNC(TM) Neurostimulation Console in Alzheimer's Disease Program FDA feedback provides clear framework for Nexalin's planned U.S. Pilot Study and supports a potential De Novo pathway for the Gen-2 SYNC(TM) device in Alzheimer's disease GlobeNewswire December 03, 2025 HOUSTON, TX, Dec. 03, 2025 (GLOBE NEWSWIRE) — Nexalin Technology,

AmpliTech Group Receives Nearly $5 Million in Follow-On Orders From LOI Customers

AmpliTech Group Receives Nearly $5 Million in Follow-On Orders From LOI Customers Company Provides Business Update as ORAN 5G, Satcom, and Private 5G Programs Progress GlobeNewswire December 03, 2025 HAUPPAUGE, N.Y., Dec. 03, 2025 (GLOBE NEWSWIRE) — AmpliTech Group, Inc. (NASDAQ: AMPG) (“AmpliTech” or the “Company”) today announced that it has received nearly US$5 million

Country Music Artist Superstar Blake Shelton Joins “The Michael Waddell Podcast”

Country Music Artist Superstar Blake Shelton Joins “The Michael Waddell Podcast” Shelton and Waddell Trade Songs and Stories in New Podcast Episode GlobeNewswire December 03, 2025 DENVER, CO, Dec. 03, 2025 (GLOBE NEWSWIRE) — Country music artist, TV personality, and outdoorsman, Blake Shelton, joins Michael Waddell on the latest The Michael Waddell Podcast, presented by

Annovis To Present at the 2025 Annual Meeting of the Parkinson Study Group

Annovis To Present at the 2025 Annual Meeting of the Parkinson Study Group GlobeNewswire December 03, 2025 MALVERN, Pa., Dec. 03, 2025 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD),

RIX Industries Opens New Center of Excellence for Advanced Development Near Company Headquarters

RIX Industries Opens New Center of Excellence for Advanced Development Near Company Headquarters Benicia-based site strengthens collaboration, accelerates product development, and supports long-term growth strategy GlobeNewswire December 03, 2025 BENICIA, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) — RIX Industries, a recognized leader in advanced gas compression, gas generation, and precision-engineered technologies, today announced the grand

Arax Partner Firms Named to Newsweek’s Top Financial Advisory Firms 2026

Arax Partner Firms Named to Newsweek's Top Financial Advisory Firms 2026 GlobeNewswire December 03, 2025 NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) — Arax Investment Partners (“Arax” or the “Company”), a premier wealth management firm backed by RedBird Capital Partners (“RedBird”), is pleased to announce that partner firms Ashton Thomas and U.S. Capital Wealth have

Arrakis Therapeutics Presents Data Highlighting Progress of Oral RNA-targeted Small Molecule to Treat Myotonic Dystrophy Type 1 (DM1)

Arrakis Therapeutics Presents Data Highlighting Progress of Oral RNA-targeted Small Molecule to Treat Myotonic Dystrophy Type 1 (DM1) GlobeNewswire December 03, 2025 Preclinical in vivo data demonstrate hyper-precise mechanism directly targets the disease-causing mRNA repeats leading to correction of splicing defects and reversal of myotonia Oral administration of lead drug candidate results in broad biodistribution,

Scroll to Top